Contribute
| IIT AGNE Welcome To New Indian Students In Boston |
Press Release
11/04/2015
IIT AGNE invites all Indian graduate and undergraduate students in the Boston area to an afternoon where you will learn about career and entrepreneurship opportunities from successful entrepreneurs working in the exciting Boston startup ecosystem, spanning multiple areas such as life sciences, biotechnology and medical devices
The details of the event are as follows. Please RSVP We look forward to seeing you all!
What: Welcome for Indian students in Boston with tea and snacks
When: 14th November 2015, 2pm-4pm
Where: Kirsch Auditorium, Ray and Maria Stata Center, Room 32-132
Registration: Free of cost. Please RSVP here.
Speakers:
Healthcare and Life Sciences Panel:
Parag Mehta, CEO, Aveta Biomics
Dr.
Parag Mehta is the CEO of Aveta Biomics, a life sciences company
founded by a team of physicians and scientists, which was born out of a
desire to develop effective solutions based on the principles of
integrative medicine. He is a successful business executive and
entrepeneur with over 20 years of experience in science, technology and
life sciences.PJ Anand is the founder of Alcyone Lifesciences, which was started in 2010 to address the large unmet need in treatment of difficult neuropathological conditions. PJ's career in the life sciences and pharmaceutical industry includes 18 years of experience in operational, business and corporate development roles.
Purnanand Sarma, President & CEO, Taris Biomedical
Dr. Purnand Sarma is President & CEO of Taris Biomedical, a specialty pharmaceutical Company, focused on treating genito-urinary diseases using drug-device convergence. He recently sold his company's lead program LiRIS for the treatment of Interstitial Cystitis to Allergan. He has more than 15 years of pharmaceutical experience and has been involved in all aspects of the drug delivery business.
Niven Narain, Co-founder, President and CTO, Berg
Dr.Niven R. Narain is Co-Founder, President & CTO of Berg, a Boston-based biopharma company housing fully integrated discovery, clinical, analytics, and diagnostics divisions. He is inventor of the Interrogative Biologyâ„¢ drug discovery platform that has produced and guided clinical development of lead molecules in cancer and diabetes by combining elements of biological models, Big Data analytics, artificial intelligence, genomics, proteomics, lipidomics, and metabolomics.
|
You may also access this article through our web-site http://www.lokvani.com/
